VAXCYTE INC (PCVX)

US92243G1085 - Common Stock

74.57  -0.88 (-1.17%)

After market: 74.57 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
436.33M393.04M209.26M103.67M89.58M
Research and Development
346.30M268.07M135.68M60.94M73.56M
Selling, General, and Administrative Expenses
90.03M124.97M73.59M42.74M16.02M
Operating Income
-436.33M-393.04M-209.26M-103.67M-89.58M
Interest Income/Expense
70.25M61.01M6.88M2.01M-2.11M
Other Income/Expense
4.23M4.76M1.93M1.59M2.48M
Non Recurring Items
N/A-75.00M-23.04MN/AN/A
Income Before Taxes
-436.82M-402.27M-223.49M-100.08M-89.22M
Net Income
-436.82M-402.27M-223.49M-100.08M-89.22M
EBITDA
-432.88M-389.88M-206.68M-101.87M-88.17M
 
Per Share Data
EPS Diluted Total Ops
-4.22-4.14-3.44-1.93-3.02
Non GAAP EPS
-4.28-4.13-3.43-1.93N/A
 
Statistics

All data in USD

Charts